Seelos Therapeutics, Inc. (SEEL) Social Stream



Seelos Therapeutics, Inc. (SEEL): $1.18

-0.07 (-5.60%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SEEL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

Seelos Therapeutics Inc (SEEL) Price Targets From Analysts

Use the tables below to see what analysts covering Seelos Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 6 $14 $6 $9.5 $1.25 660%

The Trend in the Analyst Price Target


SEEL's average price target has moved up $1.5 over the prior 46 weeks.

Over the past 44 weeks, SEEL's average upside potential has been 234.45%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-09 6 14 6 9.50 2.29 314.85%
2021-07-10 5 15 4 9.50 2.65 258.49%
2021-06-13 4 15 4 9.75 3.36 190.18%
2021-06-05 4 15 4 9.75 3.38 188.46%
2021-08-07 5 15 4 9.50 2.17 337.79%

SEEL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 31 days, SEEL's average broker recommendation rating improved by 0.67.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SEEL has a greater upside potential (average analyst target price relative to current price) than 98.31% of all US stocks.
  • Seelos Therapeutics Inc's variance in analysts' estimates is lower than 11.06% of stocks in the small market cap category.
  • In terms of how Seelos Therapeutics Inc fares relative to Healthcare stocks, note that its average analyst price target is higher than 14.93% of that group.
  • In terms of how Seelos Therapeutics Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 78.87% of that group.

In the Pharmaceutical Products industry, SBTX, RYTM, and RXDX are the three stocks most similar to Seelos Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is SEEL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6911 seconds.